These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 8445289

  • 21. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.
    Patrignani P, Filabozzi P, Catella F, Pugliese F, Patrono C.
    J Pharmacol Exp Ther; 1984 Feb; 228(2):472-7. PubMed ID: 6537977
    [Abstract] [Full Text] [Related]

  • 22. Thromboxane synthesis inhibition and renal allograft function.
    Anderson C, Jendrisak M, Brunt E, Tobimatsu M, Murphy M, Sicard G, Mangino M.
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1161-4. PubMed ID: 2650085
    [Abstract] [Full Text] [Related]

  • 23. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T, Maeda K, Shibata M, Yamada K.
    Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
    [Abstract] [Full Text] [Related]

  • 24. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
    Grauer GF, Greco DS, Behrend EN, Fettman MJ, Mani I, Getzy DM, Reinhart GA.
    Am J Vet Res; 1996 Jun; 57(6):948-56. PubMed ID: 8725828
    [Abstract] [Full Text] [Related]

  • 25. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
    van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F.
    J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
    [Abstract] [Full Text] [Related]

  • 26. A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.
    Nyberg G, Larsson O, Westberg NG, Aurell M, Jagenburg R, Blohmé G.
    Clin Nephrol; 1984 Mar; 21(3):184-7. PubMed ID: 6705280
    [Abstract] [Full Text] [Related]

  • 27. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H, Kanno Y, Nakamoto H, Okada H, Sugahara S.
    Clin Exp Hypertens; 2005 Mar; 27(2-3):129-38. PubMed ID: 15835375
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
    Nagao T, Nagamatsu T, Suzuki Y.
    Eur J Pharmacol; 1996 Nov 28; 316(1):73-80. PubMed ID: 8982653
    [Abstract] [Full Text] [Related]

  • 33. Renal function and urinary prostaglandins in rats given an adenine diet.
    Yokozawa T, Chung HY, Lee TW, Oura H.
    Nihon Jinzo Gakkai Shi; 1989 Jun 28; 31(6):671-5. PubMed ID: 2795996
    [Abstract] [Full Text] [Related]

  • 34. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor.
    Carter AJ, Bevan JA, Hanley SP, Morgan WE, Turner DR.
    Thromb Haemost; 1984 Apr 30; 51(2):257-60. PubMed ID: 6377567
    [Abstract] [Full Text] [Related]

  • 35. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL, Finomo FO, Kadiri S, Arije A, Olatosin AO.
    Afr J Med Med Sci; 2002 Mar 30; 31(1):53-7. PubMed ID: 12518931
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
    Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ, FitzGerald GA.
    J Pharmacol Exp Ther; 1999 May 30; 289(2):735-41. PubMed ID: 10215647
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.